Type I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure-1/1022/
Dr. Jerry Nadler, Professor of Medicine, Chief of the Division of Endocrinology and Metabolism and Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA discusses his Type I diabetes research looking for a two-drug cure.
Management of Type I Diabetes in Young Children
https://reachmd.com/programs/focus-on-diabetes/management-of-type-i-diabetes-in-young-children/3840/
Over 40 children a day are diagnosed with type I diabetes in the United States. What are the clinical management issues pediatric practitioners face today? Joining host Dr. Mary Leuchars is Dr. H. Peter Chase, professor of pediatrics at the University of Colorado Health Sciences Center and past-exec
Type I diabetes - How close are we to a cure?
https://reachmd.com/programs/clinicians-roundtable/type-i-diabetes-how-close-are-we-to-a-cure/1020/
Dr. Raghu Mirmira, Associate Professor of Medicine and Associate Director of the Diabetes and Hormone Center of Excellence at the University of Virginia School of Medicine in Charlottesville, VA is here to discuss his work with transcription factors, the timing of their expression, the genes they ta
Vitamin D₂ May Help Preserve Honeymoon Phase of Type I Diabetes
https://reachmd.com/news/vitamin-d2-may-help-preserve-honeymoon-phase-of-type-i-diabetes/2462310/
by Bob Yirka , Medical Xpress …
Under-the-Skin Implant Could Treat Type I Diabetes
https://reachmd.com/news/under-the-skin-implant-could-treat-type-i-diabetes/2453427/
A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while avoiding the immunosuppression that typically stymies management of the disea…
Breakthrough Drug Helps Children with New-Onset Type 1 Diabetes: Phase 3 Trial
https://reachmd.com/news/breakthrough-drug-helps-children-with-new-onset-type-1-diabetes-phase-3-trial/2452865/
Credit: CC0 Public Domain Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports. Worldwide, about 8.4 million people have type 1 diabetes, an …
Novel Treatments for Diabetes
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/novel-treatments-for-diabetes/1787/
Dr. Lazar discusses exciting new innovations in our approach to both type I and type II diabetes including Islet cell transplantation, medications for beta cell preservation and new insights into the control of obesity.
https://reachmd.com/programs/clinicians-roundtable/the-diabetic-investor/1642/
Join host Larry Kaskel interview David Kliff, a diabetic himself and the publisher of the Diabetic Investor. Should you invest in the Diabetes Sector? What drug companies will pick up the Avandia business? Find out in this segment.
Do We Already Have the Cure for Type 1 Diabetes?
https://reachmd.com/programs/focus-on-diabetes/do-we-already-have-the-cure-for-type-1-diabetes/3852/
We spend billions each year to research possible cures for type I diabetes, but the cure may already be on the shelf. Join host Dr. Bruce Bloom and his guest, Dr. Denise L. Faustman, associated professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at Massach
Pennington Biomedical to Conduct Glycemic Control Study for Patients Living with Diabetes
https://reachmd.com/news/pennington-biomedical-to-conduct-glycemic-control-study-for-patients-living-with-diabetes/2453130/
VITAL-CGM study, to evaluate effects of data provided by use of a continuous glucose monitor paired with behavioral weight management using WeightWatchers Diabetes Program For more informa…